The Latest Breaking News from ALBO

When Jim Flanagan discovered he was being evicted from his home it became a national story, due to the fact that his landlord was Prime Minister Anthony Albanese. However, the misinformation and media-manhunt that followed made his life “hell on earth” he told PEDESTRIAN.TV. Jim has spent the last four…

Newcastle Herald letters to the editor for Friday, April 19.

Albireo Pharma (NASDAQ:ALBO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Albireo Pharma missed estimated earnings by 18.38%, reporting an EPS of $-2.19 versus an estimate of $-1.85.

Albireo Pharma (NASDAQ:ALBO) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Albireo Pharma will report an earnings per share (EPS) of $-1.85.

"Zoom in mate."

Newcastle Herald readers have their say

Benzinga Pro data, Albireo Pharma (NASDAQ:ALBO) reported Q4 sales of $32.52 million. Earnings fell to a loss of $10.96 million, resulting in a 119.2% decrease from last quarter.

  Albireo Pharma (NASDAQ:ALBO) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:30 AM. Here's what investors need to know about the announcement.